Yu-Ming Guo (Yuming Guo)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Perovskite Solar Cells

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

Physical chemistry chemical physics : PCCP

Chemical communications (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Lili Meng, Lingxue Tang, Fangli Gao, Liang Zhu, Xinhe Liu, Jie Zhang, Yi Chang, Xiaoming Ma, Yu-Ming Guo
Hollow CeO 2 -Based Nanozyme with Self-Accelerated Cascade Reactions for Combined Tumor Therapy. Chemistry (Weinheim an der Bergstrasse, Germany) 30 (49) (2024)
Lili Meng, Lingxue Tang, Fangli Gao, Liang Zhu, Xinhe Liu, Jie Zhang, Yi Chang, Xiaoming Ma, Yu-Ming Guo
Hollow CeO 2 -Based Nanozyme with Self-Accelerated Cascade Reactions for Combined Tumor Therapy. Chemistry (Weinheim an der Bergstrasse, Germany) (2024)
Chang-Xun Dou, Xu-Ke Tian, Ying-Jun Chen, Pei-Pei Yin, Jia-Hui Guo, Xiao-Gang Yang, Yu-Ming Guo, Lu-Fang Ma
Fast photocatalytic degradation of rhodamine B using indium-porphyrin based cationic MOF under visible light irradiation. Physical chemistry chemical physics : PCCP (2023)
Yi Chang, Tingting Liu, Peng Liu, Lili Meng, Shujun Li, Yu-Ming Guo, Lin Yang, Xiaoming Ma
Biomineralized nanosilica-based organelles endow living yeast cells with non-inherent biological functions. Chemical communications (Cambridge, England) 56 (42) (2020)
Yi Chang, Huijuan Han, Tingting Liu, Shibao Yuan, Shuting Chen, Yu-Ming Guo, Lin Yang, Xiaoming Ma
Cell-tailored calcium carbonate particles with different crystal forms from nanoparticle to nano/microsphere. RSC advances 10 (70) (2020)
Shouning Yang, Meng Wang, Yanmin Zhang, Feng Li, Shaoning Yu, Lin Zhu, Yu-Ming Guo, Lin Yang, Shouning Yang
Conformational-transited protein corona regulated cell-membrane penetration and induced cytotoxicity of ultrasmall Au nanoparticles. RSC advances 9 (8) (2019)
Ge Wang, Jing Liu, Lin Zhu, Yu-Ming Guo, Lin Yang
Silver sulfide nanoparticles for photodynamic therapy of human lymphoma cells via disruption of energy metabolism. RSC advances 9 (51) (2019)